IRIS

1.1 Articolo in rivista: [26266] Home page tipologia

Sfoglia
Prodotti della tipologia (ordinati per Data di deposito in Decrescente ordine): 321 a 340 di 26.266
Titolo Data di pubblicazione Autore(i) File
Sex and cancer immunotherapy: Current understanding and challenges 1-gen-2022 Pala, Laura; De Pas, Tommaso; Catania, Chiara; Giaccone, Giuseppe; Mantovani, Alberto; Minucci, Saverio; Viale, Giuseppe; Gelber, Richard D; Conforti, Fabio
Gender-Based Differences in the Efficacy of Anti-EGFR/BRAF/MEK Targeted Therapy in Patients with BRAF-Mutated Metastatic Colorectal Cancer 1-gen-2025 Pala, Laura; De Pas, Tommaso; Cocorocchio, Emilia; Catania, Chiara; Ceresoli, Giovanni; Laszlo, Daniele; Zattarin, Emma; Rossi, Giovanna; Conforti, Fabio
A phase II study of regorafenib in patients with thymic epithelial tumours previously treated with chemotherapy 1-gen-2018 Perrino, M; Bozzarelli, S; Zucali, Pa; De Pas, Tm; Simonelli, M; De Vincenzo, F; Conforti, F; Persico, P; Miggiano, C; Cordua, N; Cioffi, A; Sala, S; Sposta, Fm; Giordano, L; Santoro, A
Antitumor activity of sorafenib and imatinib in a patient with thymic carcinoma harboring c-KIT exon 13 missense mutation K642E 1-gen-2014 Catania, C; Conforti, F; Spitaleri, G; Barberis, M; Preda, L; Noberasco, C; Lazzari, C; Toffalorio, F; De Marinis, F; Manzotti, M; De Pas, Tm
Sex as a predictor of response to cancer immunotherapy Reply 1-gen-2018 Conforti, F; Pala, L; Bagnardi, V; De Pas, T; Marco, M; Viale, G; Gelber, R; Goldhirsch, A
Exon-18-EGFR Mutated Transformed Small-Cell Lung Cancer: A Case Report and Literature Review 1-gen-2023 Digiacomo, N; De Pas, T; Rossi, G; Bossi, P; Stucchi, E; Conforti, F; Cocorocchio, E; Laszlo, D; Pala, L; Zattarin, E; Catania, C
Primary ipilimumab/nivolumab immunotherapy followed by adjuvant nivolumab in patients with locally advanced or oligometastatic melanoma: Update on outcome 1-gen-2021 Cocorocchio, E; Nezi, L; Gandini, S; Manzo, T; Mazzarella, L; Lotti, F; Pala, L; Gnagnarella, P; Conforti, F; Pennacchioli, E; Fierro, Mt; Ribero, S; Senetta, R; Picciotto, F; Caliendo, V; Quaglino, P; Mazzarol, G; Orsolini, Gm; Prestianni, P; Ferrucci, Pf
Thymic epithelial tumors: From biology to treatment 1-gen-2020 Conforti, F; Pala, L; Giaccone, G; De Pas, T
EGFR tyrosine kinase inhibitors beyond focal progression obtain a prolonged disease control in patients with advanced adenocarcinoma of the lung 1-gen-2013 Conforti, F; Catania, C; Toffalorio, F; Duca, M; Spitaleri, G; Barberis, M; Noberasco, C; Delmonte, A; Santarpia, M; Lazzari, C; De Pas, Tm
Exemestane Plus Ovarian Function Suppression Is the Best Adjuvant Treatment of Premenopausal Women With Endocrine-Responsive Breast Cancer at Higher Risk of Relapse and With HER2-Negative Tumors 1-gen-2019 Conforti, F; Pala, L
The effect of patient sex on the efficacy and safety of anticancer immunotherapy 1-gen-2021 Pala, L; Conforti, F
Successful treatment with avapritinib in patient with mucosal metastatic melanoma 1-gen-2020 Cocorocchio, E; Pala, L; Conforti, F; Guerini-Rocco, E; De Pas, T; Ferrucci, Pf
Metaplastic breast cancers and triple-negative breast cancers of no special type: are they prognostically different? A systematic review and meta-analysis 1-gen-2022 Corso, G; D'Ecclesiis, O; Magnoni, F; Mazzotta, E; Conforti, F; Veronesi, P; Sajjadi, E; Venetis, K; Fusco, N; Gandini, S
Biological and clinical features of triple negative Invasive Lobular Carcinomas of the breast. Clinical outcome and actionable molecular alterations 1-gen-2021 Conforti, F; Pala, L; Pagan, E; Rocco, Eg; Bagnardi, V; Montagna, E; Peruzzotti, G; De Pas, T; Fumagalli, C; Pileggi, S; Pesenti, C; Marchini, S; Corso, G; Marchio, C; Sapino, A; Graffeo, R; Collet, L; Aftimos, P; Sotiriou, C; Piccart, M; Gelber, Rd; Viale, G; Colleoni, M; Goldhirsch, A
Data of Italian Cancer Centers from two regions with high incidence of SARS CoV-2 infection provide evidence for the successful management of patients with locally advanced and metastatic melanoma treated with immunotherapy in the era of COVID-19 1-gen-2020 Pala, L; Conforti, F; Saponara, M; De Pas, T; Giugliano, F; Sale, Eo; Jemos, C; Rubatto, M; Agostini, A; Quaglino, P; Fava, P; Fierro, Mt; Queirolo, P
Genetic Alterations of Melanoma Brain Metastases: A Systematic Review and Meta-Analysis 1-gen-2023 Pala, L; Bagnardi, V; Tettamanzi, F; Barberis, M; Mazzarol, G; Casali, C; De Pas, T; Pennacchioli, E; Coppola, S; Baldini, F; Cocorocchio, E; Ferrucci, P; Patane', D; Saponara, M; Queirolo, P; Conforti, F
Original Research Thymic carcinoma with Lynch syndrome or microsatellite instability, a rare entity responsive to immunotherapy 1-gen-2021 Repetto, M; Conforti, F; Pirola, S; Calvello, M; Pala, L; Bonanni, B; Catania, C; Curigliano, G; De Pas, T
Sex-based dimorphism of anticancer immune response and molecular mechanisms of immune evasion 1-gen-2021 Conforti, F.; Pala, L.; Pagan, E.; Bagnardi, V.; De Pas, T.; Queirolo, P.; Pennacchioli, E.; Catania, C.; Cocorocchio, E.; Ferrucci, P. F.; Saponara, M.; Orsolini, G.; Zagami, P.; Nicolo, E.; De Marinis, F.; Tortora, G.; Bria, E.; Minucci, S.; Joffe, H.; Veronesi, P.; Wargo, J.; Rosenthal, R.; Swanton, C.; Mantovani, A.; Gelber, R. D.; Viale, G.; Goldhirsch, A.; Giaccone, G.
Association of Anticancer Immune Checkpoint Inhibitors With Patient-Reported Outcomes Assessed in Randomized Clinical Trials A Systematic Review and Meta-analysis 1-gen-2022 Pala, L; Sala, I; Oriecuia, C; De Pas, T; Queirolo, P; Specchia, C; Cocorocchio, E; Ferrucci, P; Patane, D; Saponara, M; Pennacchioli, E; Coppola, S; Viale, G; Giaccone, G; Gelber, Rd; Bagnardi, V; Conforti, F
Immune-checkpoint inhibitors in anal squamous cell carcinoma: a systematic review and meta-analysis 1-gen-2023 Pala, L.; De Pas, T.; Stucchi, E.; Catania, C.; Cocorocchio, E.; Zampino, M. G.; Rossi, G.; Zattarin, E.; Di Muzio, A.; Laszlo, D.; Stucchi, S.; Conforti, F.
Prodotti della tipologia (ordinati per Data di deposito in Decrescente ordine): 321 a 340 di 26.266
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile

Scopri
Tipologia
  • 1 Contributo su Rivista26266
Autore
  • OYEN, Willem Jozef Gerard891
  • SANTORO, Armando799
  • CANONICA, Giorgio777
  • REPICI, Alessandro675
  • DANESE, Silvio644
  • HASSAN, CESARE643
  • FASANO, ALFONSO478
  • Marcacci, Maurilio473
  • D'INCALCI, MAURIZIO466
  • RIBOLI, Elio424
Data di pubblicazione
  • In corso di stampa10
  • 2020 - 20268444
  • 2010 - 201911540
  • 2000 - 20094513
  • 1990 - 19991428
  • 1980 - 1989308
  • 1975 - 197923
Editore
  • Edition AERCV1
  • Elsevier1
  • Futura Publishing Company1
  • Grafica Luigi Monti s.r.l.1
  • Karger, Basel1
  • Mosby1
  • sn1
  • Springer-Verlag1
  • Thieme1
Rivista
  • DIGESTIVE AND LIVER DISEASE358
  • EUROPEAN JOURNAL OF NUCLEAR MEDIC...259
  • ANNALS OF ONCOLOGY239
  • CANCERS223
  • THE JOURNAL OF NUCLEAR MEDICINE221
  • PLOS ONE211
  • EUROPEAN JOURNAL OF CANCER197
  • GASTROINTESTINAL ENDOSCOPY193
  • ALLERGY178
  • JOURNAL OF CLINICAL ONCOLOGY169
Keyword
  • Humans2102
  • Female1005
  • Male964
  • Middle Aged745
  • Aged643
  • Adult550
  • COVID-19408
  • Treatment Outcome359
  • Animals321
  • Retrospective Studies262
Lingua
  • eng18439
  • ita405
  • spa13
  • fre11
  • ger8
  • enm3
  • por2
  • chi1
  • und1
Accesso al fulltext
  • no fulltext24066
  • reserved1312
  • open888